Meningococcal disease – probable transmission during an international flight
DOI:
https://doi.org/10.33321/cdi.2005.29.35Keywords:
chemoprophylaxis, disease surveillance, meningococcal disease, transmission, travellers, aeroplane travelAbstract
Two cases of meningococcal disease were identified in passengers who travelled on the same international flight. Both cases were serogroup B with the same allelic profile. The public health action involved chemoprophylaxis for persons seated adjacent to, and in the rows in front and behind, each case. The most likely scenario is that transmission of N. meningitidis occurred on board a long distance flight, either from one case to the other or from an asymptomatic carrier to both cases. This scenario and the absence of reports of similar cases in the literature, indicate the risk to other passengers in this setting is low. This investigation reinforces the need for, and the distribution of, good national and international surveillance information to better inform public health decision making. Commun Dis Intell 2005;29:312–314.
Downloads
References
Mangili A, Gendreau MA. Transmission of infectious diseases during commercial air travel. Lancet 2005; 365:989–996.
Olsen SJ, Chang HL, Cheung TY, Tang AF, Fisk TL, Ooi SP, et al. Transmission of the severe acute respiratory syndrome on aircraft. N Engl J Med 2003;349:2416–2422.
Marsden AG. Influenza outbreak related to air travel. Med J Aust 2003;179:172–173.
Kenyon TA, Valway SE, Ihle WW, Onorato IM, Castro KG. Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med 1996;334:933–938.
Centers for Disease Control and Prevention. Exposure to patients with meningococcal disease on aircrafts—United States, 1999–2001. MMWR Morb Mortal Wkly Rep 2001;50:485–489.
Leder K, Newman D. Respiratory infections during air travel. Intern Med J 2005;35:50–55.
Wenzel RP. Airline travel and infection. N Engl J Med 1996;334:981–982.
World Health Organization. Tuberculosis and air travel: guidelines for prevention and control. WHO/TB98.256. Geneva, Switzerland, World Health Organization: 1998.
Taha MK. Molecular detection and characterization of Neisseria meningitidis. Expert Rev Mol Diagn 2002;2:143–150.
Sacchi CT, Lemos AP, Whitney AM, Solari CA, Brandt ME, Melles CE, et al. Correlation between serolgical and sequencing analyses of the PorB outer mambrane protein in the Neisseria meningitidis serotyping system. Clin Diagn Lab Immunol 1998;5:348–354.
Sacchi CT, Lemos AP, Brandt ME, Whitney AM, Melles CE, Solari CA, et al. Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature. Clin Diagn Lab Immunol 1998;5:845–855.
Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 1998;95:3140–3145.
http://www.neisseria.org/nm/typing
The Australian Meningococcal Surveillance Programme. Annual report of the Australian Meningococcal Surveillance Programme, 2003. Commun Dis Intell 2004;28:194–206.
Communicable Diseases Network Australia. Guidelines for the Early Clinical and Public Health Management of Meningococcal Disease in Australia. Canberra, Commonwealth of Australia. 2001.
Communicable Diseases Network Australia. Follow-up of communicable diseases reported among travellers on aeroplanes. Commun Dis Intell 2004;28:270–272.
Public Health Laboratory Service Meningococcus Forum. Guidelines for public health management of meningococcal disease in the UK. Commun Dis Public Health 2002;5:187–204.
Begg N. Policies for public health management of meningococcal disease. J Epidemiol Community Health 1999;53:516.
Downloads
Published
How to Cite
License
Copyright (c) 2005 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
